Pharma News

Pharma Courses  

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Lilly's Oral GLP-1, Orforglipron, Demonstrated Superior Glycemic Control in Two Successful Phase 3 Trials
    15 October 2025

    Lilly's Oral GLP-1, Orforglipron, Demonstrated Superior Glycemic Control in Two Successful Phase 3 Trials

    Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the Phase 3 ACHIEVE-2 and ACHIEVE-5 trials. ACHIEVE-2, the second head-to-head trial in the program, evaluated orforglipron versus dapagliflozin, an SGLT-2 inhibitor, in adults with type 2 diabetes inadequately controlled on metformin.
  • 15 October 2025
    Molecular markers and risk models guide precision care in liver cancer surgery
    Liver cancer remains one of the worlds most lethal cancers, ranking as the third leading cause of cancer-related deaths. Although surgical advances have improved safety, recurrence after hepatectomy continues to be a major challenge.
  • 15 October 2025
    Ateneo scientists research potential anti-ulcer vaccine
    Since ancient times, it was thought that painful stomach ulcers were caused by eating spicy foods or having an unhealthy diet. But since then, researchers have found that Helicobacter pylori a common bacterium found in over 60% of the world’s population—was the real culprit behind most stomach ulcers and a high risk for stomach cancer.
  • 14 October 2025
    AstraZeneca Reaches Landmark Agreement with Trump Administration to Cut U.S. Drug Prices, Invest 50 Billion USD in Domestic Manufacturing

    AstraZeneca has announced a historic agreement with President Donald J. Trump’s administration to reduce the cost of prescription medicines for American patients while maintaining the nation’s leadership in biopharmaceutical innovation.

    At a White House event, AstraZeneca CEO Pascal Soriot joined President Trump and senior officials to confirm that the company has voluntarily met all four requests outlined in the President’s July 31 letter. The agreement enables American patients to access AstraZeneca medicines at prices aligned with those in other wealthy nations.

  • 11 October 2025
    IDMA 3rd National cGMP Day 2025 organized by Saveetha College of Pharmacy

    Saveetha College of Pharmacy, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai; with a focus on strengthening compliance and promote a culture of quality within the pharmaceutical industry and academia; observed and celebrated theIndian Drug Manufacturers Association (IDMA)3rd National Current Good Manufacturing Practices (cGMP) Dayjointly in association with the Indian Pharmaceutical Association (IPA) Hospital Pharmacy Division, held on October 10, 2025; by organizing an Expert Talk and cGMP Sensitizing Program emphasizing the critical role of current Good Manufacturi

  • 11 October 2025
    FDA Confirms DEG / EG contaminated cough syrups in India, Not exported to U.S.
    The U.S. Food and Drug Administration (FDA) has acknowledged reports of severe and ongoing contamination involving diethylene glycol (DEG) and ethylene glycol (EG) in children’s cough and cold medicines in India. The agency confirmed that these contaminated products have not been shipped to the United States.
  • 11 October 2025
    WHO announces the development of new recommendations on HTLV-1
    HTLV‑1 – the first human retrovirus to be identified, in 1977 – affects at least 5-10 million people globally. It is concentrated in western and central Africa, Latin America, and the Western Pacific Region.
  • 10 October 2025
    NATCO Pharma Wins Landmark Legal Battle to Launch Affordable Risdiplam for Spinal Muscular Atrophy in India

    NATCO Pharma Limited has announced a significant legal victory in its ongoing patent dispute with Roche, enabling the company to launch its generic version of Risdiplam, a drug used in the treatment of Spinal Muscular Atrophy (SMA), in India.

  • 10 October 2025
    CDSCO Directs Strict Compliance with Drug Testing Rules Following Reports of Cough Syrup-Linked Deaths
    The Central Drugs Standard Control Organization (CDSCO) has issued a directive to all State and Union Territory Drug Controllers, stressing the need for strict compliance with the Drugs Rules, 1945, in testing raw materials and finished pharmaceutical formulations.
  • 9 October 2025
    National Pharmacovigilance Week 2025 celebration organized by Saveetha College of Pharmacy

    Saveetha College of Pharmacy, Saveetha Institute of Medical and Technical Sciences (SIMATS) Chennai, in collaboration with the Indian Pharmaceutical Association (IPA) Hospital Pharmacy Division, celebrated National Pharmacovigilance Week (NPW 2025).

    This initiative aimed to raise awareness among healthcare professionals, regulators, researchers, and the general public about the importance of actively reporting adverse drug reactions (ADRs) using simplified digital platforms.

Subscribe to Pharma News